SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001085037-23-000114
Filing Date
2023-10-19
Accepted
2023-10-19 13:45:23
Documents
7
Period of Report
2023-10-19

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k101923.htm 6-K 7875
2 EXHIBIT 99.1 - NEWS RELEASE DATED OCTOBER 11, 2023 ex99_1.htm EX-99.1 13439
3 MATERIAL CHANGE REPORT DATED OCTOBER 12, 2023 ex99_2.htm EX-99.2 7238
4 EXHIBIT 99.3 - NEWS RELEASE DATED OCTOBER 16, 2023 ex99_3.htm EX-99.3 2585
5 EXHIBIT 99.4 - MATERIAL CHANGE REPORT DATED OCTOBER 17, 2023 ex99_4.htm EX-99.4 4833
6 image00002.jpg GRAPHIC 4679
7 image00003.jpg GRAPHIC 2545
  Complete submission text file 0001085037-23-000114.txt   47492
Mailing Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1
Business Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1 604-248-8693
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-50112 | Film No.: 231334344
SIC: 2836 Biological Products, (No Diagnostic Substances)